Image 01
A sequence listing showing the amino acid sequence of Cosyntropin, with each residue named and numbered from 1 to 24 in a linear format.*
Cosyntropin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0781-3440
2 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cosyntropin (NDC 0781-3440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
Cosyntropin for Injection 0.25 mg/vial powder label for lyophilized intravenous solution by Sandoz Inc. The label indicates it is for diagnostic use only, single dose, must be diluted before use, and discard unused portion. Storage instructions specify controlled room temperature 20°C to 25°C. Includes the product NDC 0781-3440-71.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
